AIRLINK 80.60 Increased By ▲ 1.19 (1.5%)
BOP 5.26 Decreased By ▼ -0.07 (-1.31%)
CNERGY 4.52 Increased By ▲ 0.14 (3.2%)
DFML 34.50 Increased By ▲ 1.31 (3.95%)
DGKC 78.90 Increased By ▲ 2.03 (2.64%)
FCCL 20.85 Increased By ▲ 0.32 (1.56%)
FFBL 33.78 Increased By ▲ 2.38 (7.58%)
FFL 9.70 Decreased By ▼ -0.15 (-1.52%)
GGL 10.11 Decreased By ▼ -0.14 (-1.37%)
HBL 117.85 Decreased By ▼ -0.08 (-0.07%)
HUBC 137.80 Increased By ▲ 3.70 (2.76%)
HUMNL 7.05 Increased By ▲ 0.05 (0.71%)
KEL 4.59 Decreased By ▼ -0.08 (-1.71%)
KOSM 4.56 Decreased By ▼ -0.18 (-3.8%)
MLCF 37.80 Increased By ▲ 0.36 (0.96%)
OGDC 137.20 Increased By ▲ 0.50 (0.37%)
PAEL 22.80 Decreased By ▼ -0.35 (-1.51%)
PIAA 26.57 Increased By ▲ 0.02 (0.08%)
PIBTL 6.76 Decreased By ▼ -0.24 (-3.43%)
PPL 114.30 Increased By ▲ 0.55 (0.48%)
PRL 27.33 Decreased By ▼ -0.19 (-0.69%)
PTC 14.59 Decreased By ▼ -0.16 (-1.08%)
SEARL 57.00 Decreased By ▼ -0.20 (-0.35%)
SNGP 66.75 Decreased By ▼ -0.75 (-1.11%)
SSGC 11.00 Decreased By ▼ -0.09 (-0.81%)
TELE 9.11 Decreased By ▼ -0.12 (-1.3%)
TPLP 11.46 Decreased By ▼ -0.10 (-0.87%)
TRG 70.23 Decreased By ▼ -1.87 (-2.59%)
UNITY 25.20 Increased By ▲ 0.38 (1.53%)
WTL 1.33 Decreased By ▼ -0.07 (-5%)
BR100 7,629 Increased By 103 (1.37%)
BR30 24,842 Increased By 192.5 (0.78%)
KSE100 72,743 Increased By 771.4 (1.07%)
KSE30 24,034 Increased By 284.8 (1.2%)
World

Seven million Italians seen fully vaccinated by end-March

  • Pfizer and Moderna doses will be administered in parallel, to those over 80 and most exposed to risks, such as health workers.
  • "Meanwhile, the number of Italians that are fully vaccinated will top 1 million today," he said during a weekly press event.
Published February 5, 2021

MILAN: If vaccine supplies are confirmed, seven million Italians could be fully vaccinated against COVID-19 by the end of March, the government's special commissioner Domenico Arcuri said on Friday.

Arcuri said the first 249,600 doses of the AstraZeneca vaccine will arrive in Italy on Saturday and will be administered from next week, to people up to the age of 55.

Pfizer and Moderna doses will be administered in parallel, to those over 80 and most exposed to risks, such as health workers.

"Meanwhile, the number of Italians that are fully vaccinated will top 1 million today," he said during a weekly press event.

Israel is currently far ahead of the rest of the world on vaccinations per head of population, followed by the United Arab Emirates, the United Kingdom, Bahrain, the United States and then Spain, Italy and Germany.

Britain on Thursday launched a trial to assess the immune responses generated if doses of the vaccines from Pfizer and AstraZeneca are combined in a two-shot schedule. Initial data on immune responses is expected around June.

Arcuri said Italy was the first European country in terms of the number of people who have received both the first and second dose of vaccines, ahead of Germany.

"We have about one million people who have received both the first and second dose, ahead of Germany with 756,000," he told the news conference.

Asked about recent production disruptions and supply cuts, the commissioner said he was waiting for the EU and the vaccine manufacturers to agree over the proposal to transfer part of their production to local sites to increase capacity.

"We believe Italy has the facilities and the characteristics to contribute to an increase in production," he added.

Italy was among a number of European countries that filed a petition with the EU Commission proposing that pharmaceutical companies also produce vaccines locally.

Italy has been one of the hardest-hit countries since the epidemic emerged a year ago.

The virus has killed 90,241 Italians so far and infected 2.597 million, health ministry data show.

Arcuri added that the average daily number of doses administered had returned to 83,000 per day after falling by more than half in the last two weeks of January.

On the AstraZeneca vaccine, which is recommended for use in people up to 55 years old, he said he was confident that "further trials may allow it to be used within a wider share of the population."

Comments

Comments are closed.